DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)

22.94 +0.18 (+0.79%) At close: 03:00PM CST

DaShenLin Pharmaceutical Group Co., Ltd.

No. 410-1, Longxi Avenue
Liwan District
Guangzhou 51000
China
86 20 8128 4688
https://www.dslyy.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 45,466

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Guoqiang Ke	General Manager	N/A	N/A	1982
Mr. Guangzhi Peng	Financial Controller	N/A	N/A	1982
Mr. Run Shi Liang	Secretary of the Board	N/A	N/A	1993
Mr. Zhi Hui Chen	Chairman of Supervisory Board & Deputy Director of Human Resources Department - Guangdong Province	N/A	N/A	1978

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Corporate governance

DaShenLin Pharmaceutical Group Co., Ltd.’s ISS governance QualityScore as of 1 May 2024 is 5. The pillar scores are Audit: 5; Board: 9; Shareholder rights: 2; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.